2/2/23 16:33 | 2/1/23 | PRPH | Prophase Labs, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Karkus Ted William | NY | DOT | CEO,CB | M.d | 300 | 0.6000 | 0 | 500 | 16 | 3,684 | D | | | | | | | | | | | | | | |
1/17/23 16:37 | 1/13/23 | PRPH | Prophase Labs, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Karkus Ted William | NY | DOT | CEO,CB | M.d | 360 | 0.6000 | 0 | 600 | 21 | 3,452 | D | | | | | | | | | | | | | | |
10/18/22 09:34 | 10/16/22 | PRPH | Prophase Labs, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Karkus Ted William | NY | DOT | CEO,CB | M.d | 360 | 0.6000 | 0 | 600 | 23 | 3,171 | D | | | | | | | | | | | | | | |
8/10/22 21:23 | 8/10/22 | PRPH | Prophase Labs, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Karkus Ted William | NY | DOT | CEO,CB | M.d | 360 | 0.6000 | 0 | 600 | 26 | 2,889 | D | | | | | | | | | | | | | | |
5/25/22 17:20 | 5/23/22 | PRPH | Prophase Labs, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Karkus Ted William | NY | DOT | CEO,CB | M.d | 900 | 2.00 | 0 | 450 | 21 | 2,605 | D | | | | | | | | | | | | | | |
6/10/21 16:01 | 6/3/21 | PRPH | Prophase Labs, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Karkus Ted William | NY | DOT | CEO,CB | P | 172 | 5.07 | 0 | 34 | 1 | 2,333 | D | | | | | | | | | | | | | | |
8/17/20 16:30 | 8/13/20 | PRPH | Prophase Labs, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Karkus Ted William | PA | DOT | CEO,CB | S | -138 | 2.75 | 0 | -50 | -2 | 2,500 | D | | | | | | | | | | | | | | |
3/27/20 19:15 | 3/26/20 | PRPH | Prophase Labs, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Karkus Ted William | PA | DOT | CEO,CB | S | -175 | 1.75 | 0 | -100 | -4 | 2,550 | D | | | | | | | | | | | | | | |
5/17/18 12:40 | 5/15/18 | PRPH | Prophase Labs, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Karkus Ted William | PA | DOT | CEO,CB | M.d | 465 | 1.86 | 0 | 250 | 10 | 2,650 | D | | | | | | | | | | | | | | |
12/26/17 15:02 | 12/21/17 | PRPH | Prophase Labs, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Karkus Ted William | PA | DOT | CEO,CB | S | -977 | 2.30 | 0 | -425 | -15 | 2,485 | D | | | | | | | | | | | | | | |
12/18/17 16:00 | 12/14/17 | PRPH | Prophase Labs, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Karkus Ted William | PA | DOT | CEO,CB | M.d | 600 | 1.00 | 0 | 600 | 26 | 2,910 | D | | | | | | | | | | | | | | |
10/2/17 12:53 | 9/29/17 | PRPH | Prophase Labs, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Karkus Ted William | PA | DOT | CEO,CB | S | -839 | 2.30 | 0 | -365 | -14 | 2,310 | D | | | | | | | | | | | | | | |
6/5/15 17:25 | 6/4/15 | PRPH | Prophase Labs, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Karkus Ted William | PA | DOT | See Rema | P | 260 | 1.30 | 0 | 200 | 8 | 2,675 | D | -16 | -30 | -8 | -4 | -4 | 4 | -2 | -5 | -1 | -1 | 1 | 12 | -2 | 3 |
5/19/15 16:09 | 5/18/15 | PRPH | Prophase Labs, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Karkus Ted William | PA | DOT | CEO,CB | P.m | 283 | 1.35 | 0 | 210 | 9 | 2,475 | D | -14 | -27 | -4 | -12 | 0 | 10 | 1 | 4 | 5 | 2 | 7 | 22 | -4 | 4 |
6/26/14 18:02 | 6/23/13 | PRPH | Prophase Labs, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Karkus Ted William | PA | DOT | CEO,CB | P.m | 780 | 1.56 | 0 | 500 | 30 | 2,165 | D | 52 | -2 | -1 | -15 | -17 | -14 | -11 | 7 | 2 | -1 | -1 | -11 | -9 | -16 |
5/17/12 19:52 | 5/15/12 | PRPH | Prophase Labs, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Karkus Ted William | PA | DOT | CEO,Char | P.m | 247 | 1.01 | 0 | 245 | 18 | 1,615 | D | -40 | 11 | 19 | 0 | 11 | 2 | 4 | 5 | 7 | 1 | 9 | 1 | 50 | 38 |
11/18/11 17:25 | 11/16/11 | PRPH | Prophase Labs, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Karkus Ted William | PA | DO | CEO,CB | P | 17 | 0.8990 | 0 | 19 | 2 | 1,235 | D | -51 | -17 | 12 | 28 | 19 | 30 | 30 | 19 | 15 | 12 | -7 | -22 | -13 | 29 |
11/15/11 17:09 | 11/14/11 | PRPH | Prophase Labs, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Karkus Ted William | PA | DO | CEO,CB | P | 146 | 0.8520 | 0 | 171 | 16 | 1,216 | D | -62 | -38 | -7 | -2 | 14 | 1 | 1 | 6 | 2 | 63 | 28 | 19 | 19 | 77 |